ICD-10-CM Codes Browse (Tabular) Diagnostic External Drug Neoplasm

G13.2 – Systemic atrophy primarily affecting the central nervous system in myxedema

Coding Notes

Active

Billable, valid for HIPAA-covered transactions

Code First

underlying disease, such as:

hypothyroidism (E03.-)

myxedematous congenital iodine deficiency (E00.1)

GEM Conversion to ICD-9 CM

331.7

Fs: 10000 – Cerebral degeneration in diseases classified elsewhere

MDC / MS-DRG Reference

DRG 056

DEGENERATIVE NERVOUS SYSTEM DISORDERS WITH MCC

DRG 057

DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MCC

Sibling Codes

G13.0

Paraneoplastic neuromyopathy and neuropathy

G13.1

Other systemic atrophy primarily affecting central nervous system in neoplastic disease

G13.8

Systemic atrophy primarily affecting central nervous system in other diseases classified elsewhere

Parent Sibling Codes

G10

Huntington's disease

G11

Hereditary ataxia

G12

Spinal muscular atrophy and related syndromes

G13

Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere

G14

Postpolio syndrome

View in Tabular

Code	Title
G00-G99	Diseases of the nervous system (G00-G99)
G10-G14	Systemic atrophies primarily affecting the central nervous system (G10-G14)
G13	Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere
G13.2	Systemic atrophy primarily affecting the central nervous system in myxedema Code First underlying disease, such as: hypothyroidism (E03.-) myxedematous congenital iodine deficiency (E00.1)